Renaissance Technologies's MAZE Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 0 shares of Maze Therapeutics, Inc. (MAZE) worth $0, representing 0.00% of the portfolio. First purchased in , this recently established position has been held for 0 quarters.
Based on recent 13F filings, Renaissance Technologies has initiated a new position in MAZE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Maze Therapeutics (MAZE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Maze Therapeutics (MAZE) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| No data available | ||||
Renaissance Technologies's Maze Therapeutics Investment FAQs
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 86,100 shares of Maze Therapeutics, Inc. (MAZE), valued at approximately $2.23 M.
As of the Q3 2025 filing, Maze Therapeutics, Inc. (MAZE) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Maze Therapeutics, Inc. (MAZE) was 86,100 shares, as reported at the end of Q3 2025.